CEE
Meeting category
Date(s)
6 Oct 2016 - 7 Oct 2016
Location
Bucharest, Romania
CME Credits
1
Organizer

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Related Enduring Materials

Enduring Materials

Day 1 - Thursday, 6 October 2016

- 09:00
09:00 CEST
Opening of the meeting
Anca Streinu-Cercel, MD, PhD
National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
Session 1: Country-specific presentations -
Chairs
Anca Streinu-Cercel, MD, PhD
National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
09:10 CEST
Local situation in Romania
Oana Săndulescu, MD, PhD
Carol Davila University of Medicine and Pharmacy / National Institute for Infectious Diseases "Prof.Dr. Matei Bals", Romania
09:20 CEST
Local situation in Ukraine
Pavlo Skala
Pavlo Skala
Alliance for Public Health, Ukraine
09:30 CEST
Local situation in the Baltic countries
Saulius Caplinskas, MD, PhD
Mykolas Romeris University, Lithuania
09.40 CEST
Local situation in Slovenia and the Balcan countries
Mojca Matičič, MD, PhD
University of Ljubljana, Slovenia
09:50 CEST
Local situation in Poland
Miłosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
10:00 CEST
Local situation in Czech and Slovak Republics
Viktor Aster, MD, PHD
Charles University, Czech Republic
10:10 CEST
Local situation in Georgia
Akaki Abutidze
Akaki Abutidze, MD, MPH, PhD
nfectious Diseases, AIDS and Clinical Immunology Research Center, Georgia
10:20 CEST
Local situation in Turkey
Serhat Unal
Serhat Unal, MD
Hacettepe University School of Medicine, Turkey
10:30 CEST
Local situation in Russia
Vadim Rassokhin, MD
Pasteur Research Institute of Epidemiology and Microbiology, Russia
11:30 CEST
Industry-sponsored symposium Gilead
Session 2: Management of Hepatitis B -
Chairs
Jürgen Rockstroh, MD
University of Bonn, Germany
Andrzej Horban
Andrzej Horban, MD, PhD
Hospital for Infectious Diseases, Poland
14:00 CEST
State-of-the-art treatment of Hepatitis B
Cihan Yurdaydin, MD
Department of Gastroenterology and Hepatology, University Medical School, Istanbul, Turkey
14:30 CEST
Prospects for Cure
Patrick Kennedy
Patrick Kennedy
Imperial College Healthcare NHS Trust, UK
15:00 CEST
The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors
A. Temereanca
-
15:10 CEST
The prevalence of HBV, HCV and HIV infection in Romania - a nationwide screening program for surveillance of viral infections
O. Sandulescu
-
16:00 CEST
Industry-sponsored symposium MSD
Session 3: Management of Hepatitis Delta -
Chairs
Pavel Khaykin, MD
MainFachArzt Frankfurt, Germany
Cristina Popescu
Cristina Popescu, MD, PhD
Carol Davila University of Medicine and Pharmacy, Romania
17:00 CEST
Update of new drugs
Cihan Yurdaydin, MD
Department of Gastroenterology and Hepatology, University Medical School, Istanbul, Turkey

Day 2 - Friday, 7 October 2016

- 08:30
08:30 CEST
Industry-sponsored symposium AbbVie
Session 4: Treatment Challenges in HCV -- special populations -
Chairs
Saulius Caplinskas, MD, PhD
Mykolas Romeris University, Lithuania
Miłosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
09:30 CEST
IVDU
Pavel Khaykin, MD
MainFachArzt Frankfurt, Germany
10:00 CEST
Drug-Drug Interactions: considerations
Anca Streinu-Cercel, MD, PhD
National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
Special Session - HIV in Special Populations (ViiV) -
Chairs
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
11:00 CEST
Tackling the issues: Caring for HIV-positive women today
Anna Maria Geretti, MD, PhD, FRCPath
University of Rome, Italy / King's College London, United Kingdom
11:30 CEST
HIV and Pediatrics in Central Europe
Mariana Mărdărescu, MD, PhD
Institute for Infectious Disease Matei Bals, Romania
Session 5: Abstract driven session -- Co-infection -
Chairs
Anca Streinu-Cercel, MD, PhD
National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
Vadim Rassokhin, MD
Pasteur Research Institute of Epidemiology and Microbiology, Russia
13:00 CEST
Expression of NS4 HCV in liver cells of HIV/HCV co-infected patients
N. Matsiyeuskaya
-
13:10 CEST
HCV reinfection in HCV/HIV coinfected patients treated for VHC in AIDS Center Prague
V. Aster
-
13:20 CEST
Chronic Hepatitis C Treatment among HIV/HCV co-infected PWID in Ukraine: communitysupported treatment model experience
T. Barnard
-
13:30 CEST
Quality of life in patients with HCV/ HIV co-infection
O. Shevchenko
-
13:40 CEST
Efficiency of sofosbuvir and peginterferon alfa-2b/ribavirin in the treatment of chronic hepatitis C with genotype 1b and 3 in HIV-infected injecting drug users
M. Andreychyn
-
13:50 CEST
Predictors of HIV co-infection in HCV infected patients in Serbia
M. Stanojevic
-
14:00 CEST
Cost-efficiency versus Potency
Anca Streinu-Cercel, MD, PhD
National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
Overview
Welcome

Over 230 unique participants from 34 different countries joined the incredibly successful 2nd edition of the Central and Easter European Meeting on Viral Hepatitis and Co-infecion with HIV, held on 6 - 7 October 2016 in Bucharest, Romania.

The Organizing Committee would like to thank all invited speakers and participants for their contribution to this meeting. 

We would like to thank our supporters ViiV Healthcare, Gilead, MSD, Abbvie and  Siemens Healthineers for making this event possible.

Kind regards,

Chairs 2016

Practical Information 

Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Support
Language